Eric Routhier

Title: Eric Routhier: Innovator in Antibody Formulations

Introduction

Eric Routhier is a notable inventor based in Killingworth, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations. With a total of 2 patents, Routhier's work focuses on innovative solutions for treating complement-associated disorders.

Latest Patents

Routhier's latest patents include formulations for high concentration anti-C5 antibodies. These patents describe stable aqueous solutions that comprise a high concentration of an anti-C5 antibody, such as ravulizumab. The disclosures provide methods for preparing these solutions and outline their applications in treating or preventing disorders like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Additionally, the patents feature therapeutic kits that contain these solutions and a means for administering them to patients in need of treatment.

Career Highlights

Eric Routhier is currently employed at Alexion Pharmaceuticals, Inc., where he continues to advance his research in antibody formulations. His work has been instrumental in developing therapies that address critical health issues related to complement-associated disorders.

Collaborations

Routhier collaborates with talented professionals in his field, including Stephan Ortiz and Jillian Gentile. These partnerships enhance the innovative efforts at Alexion Pharmaceuticals, Inc. and contribute to the advancement of biotechnology.

Conclusion

Eric Routhier's contributions to the field of antibody formulations demonstrate his commitment to innovation in biotechnology. His patents and ongoing work at Alexion Pharmaceuticals, Inc. highlight the importance of research in developing effective treatments for complex medical conditions.